From 1 September 2025, Dydrogesterone 10mg tablets (Nalvee®) has been added to the list of medicines covered by the HRT prepayment certificate (HRT PPC). This change has been reflected in Part XVI of the September 2025 Drug Tariff and on the NHSBSA’s website. Community Pharmacy England has also updated its HRT medicines list to reflect the
Read moreCommunity Pharmacy England on behalf of pharmacy owners made further applications to the Department of Health and Social Care (DHSC) and the NHS Business Services Authority (NHSBSA), resulting in a further 2 new products being added to the ‘Drugs for which Discount is Not Deducted’ (DND) list from 1 September 2025. This takes the total number
Read moreWhen the revised service specification for the 2025/26 Adult Flu Vaccination service was published last month, we informed pharmacy owners that the fee for this year was still under consideration by Ministers, following our submission of an evidence-based case for an increase in the fee. The decision has now been set out in the Drug
Read moreThe Department of Health and Social Care (DHSC) has today (28/08/2025) confirmed the following list of price concessions for August 2025: Drug Pack size Price concession Acetazolamide 250mg tablets 112 £51.02 Amiodarone 100mg tablets 28 £2.24 Amiodarone 200mg tablets 28 £4.82 Buprenorphine 2mg sublingual tablets sugar free 7 £1.83 Carbocisteine 250mg/5ml oral solution 300 £4.99 Co-amoxiclav
Read moreThe Department of Health and Social Care (DHSC) has today (27/08/2025) confirmed the following list of price concessions for August 2025: Drug Pack size Price concession Betamethasone 500microgram soluble tablets sugar free 100 £31.95 Bumetanide 1mg tablets 28 £2.94 Buprenorphine 8mg sublingual tablets sugar free 7 £6.00 Co-codamol 30mg/500mg effervescent tablets 32 £2.40 Co-codamol 30mg/500mg effervescent
Read more“While implementation of the 2025/26 CPCF continues at pace, our sights are also set on the future,” writes Community Pharmacy England Chief Executive Janet Morrison in a new blog. Despite the funding uplift earlier this year, pharmacy businesses remain in a financially precarious position. Janet explains that the views of pharmacy owners and their experiences
Read moreBy Chief Executive Janet Morrison As the summer draws to a close, everyone in community pharmacy and the wider health service will be preparing, or perhaps more aptly bracing, themselves for what will undoubtedly be another frantic autumn and winter period. For community pharmacy, the announcement of the Community Pharmacy Contractual Framework (CPCF) arrangements for
Read moreFollowing a decision taken by Eli Lilly to increase its UK list prices for Mounjaro® (Tirzepatide) KwikPen® from 1 September 2025, the Department of Health and Social Care (DHSC) has re-determined the NHS reimbursement prices for all strengths of Mounjaro® dispensed from September to reflect the new, higher list prices. To avoid pharmacy owners dispensing
Read moreDapagliflozin 5mg and 10mg tablets reimbursement prices have decreased following a move from Category C to Category M in the September 2025 Drug Tariff. This comes after several manufacturers launched generic versions of Dapagliflozin tablets following the recent ruling by the UK Court of Appeal to invalidate AstraZeneca’s patent for the brand Forxiga®. More information on the
Read moreThe Drug Tariff Preface published monthly, lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 September 2025. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. n Item requiring reconstitution
Read more
